TY - JOUR
T1 - Interleukin-10 is a mesangial cell growth factor in vitro and in vivo
AU - Chadban, Steven James
AU - Tesch, Greg Hans
AU - Foti, Rita
AU - Atkins, Robert Charles
AU - Nikolic-Paterson, David John
PY - 1997/5/1
Y1 - 1997/5/1
N2 - Macrophages are involved in the pathogenesis of mesangioproliferative glomerulonephritis. As macrophages are known to produce interleukin-10 (IL- 10), we investigated the effect of recombinant murine IL-10 (rIL-10) on mesangial cell growth. In vitro studies were performed using the rat 1097 mesangial cell line. These cells exhibited a dose-dependent proliferative response to rIL-10 (23% to 70% ↑ at 80 ng/mL; p < 0.01), as assessed by both 3H-thymidine uptake and cell count. This effect was inhibited by preincubation of rIL- 10 with a neutralizing anti-IL- 10 antibody. When added to cultures of growth-arrested 1097 cells, IL-10 induced dose-dependent proliferation that paralleled the effects of platelet-derived growth factor. Incubation with a neutralizing anti-IL-10 Ab for 48 hours reduced 3H- thymidine uptake (median, 27% ↓; range, 2% to 56% ↓) versus a control Ab; p < 0.05). Rat mesangial cells were also shown to express IL-10 mRNA and protein, as determined by Northern blotting and immunostaining, thereby suggesting a role for IL-10 in autocrine mesangial cell growth. To examine the effects of IL-10 in vivo, inbred male Sprague-Dawley rats were given subcutaneous rIL-10 (0.5 mg/kg) for 3 (n = 6), 7 (n = 3), or 14 days (n = 4), or vehicle control, then killed. IL-10 administration induced a transient reduction in creatinine clearance of 35% at Day 3 (p < 0.01). Following IL- 10 administration, an increase in glomerular cellularity was seen, which was maximal at Day 3 (82.7 ± 5.9 nuclei/glomerular cross section versus control 64.6 ± 4.6, 28% ↑; p < 0.001) and maintained at Day 14 (23% ↑ ; p < 0.01). Immuno-histochemical staining for proliferating cell nuclear antigen demonstrated an increased number of proliferating cells per glomerular cross section at day 3 (48% ↑ versus controls; p < 0.05). Staining for α-smooth- muscle actin showed significant labeling only in the glomeruli of IL-10- treated animals; double-labeling with an anti-proliferating cell nuclear antigen Ab demonstrated that some of these mesangial cells were proliferating. Collectively, these results suggest that IL-10 is a growth factor for rat mesangial cells both in vitro and in vivo.
AB - Macrophages are involved in the pathogenesis of mesangioproliferative glomerulonephritis. As macrophages are known to produce interleukin-10 (IL- 10), we investigated the effect of recombinant murine IL-10 (rIL-10) on mesangial cell growth. In vitro studies were performed using the rat 1097 mesangial cell line. These cells exhibited a dose-dependent proliferative response to rIL-10 (23% to 70% ↑ at 80 ng/mL; p < 0.01), as assessed by both 3H-thymidine uptake and cell count. This effect was inhibited by preincubation of rIL- 10 with a neutralizing anti-IL- 10 antibody. When added to cultures of growth-arrested 1097 cells, IL-10 induced dose-dependent proliferation that paralleled the effects of platelet-derived growth factor. Incubation with a neutralizing anti-IL-10 Ab for 48 hours reduced 3H- thymidine uptake (median, 27% ↓; range, 2% to 56% ↓) versus a control Ab; p < 0.05). Rat mesangial cells were also shown to express IL-10 mRNA and protein, as determined by Northern blotting and immunostaining, thereby suggesting a role for IL-10 in autocrine mesangial cell growth. To examine the effects of IL-10 in vivo, inbred male Sprague-Dawley rats were given subcutaneous rIL-10 (0.5 mg/kg) for 3 (n = 6), 7 (n = 3), or 14 days (n = 4), or vehicle control, then killed. IL-10 administration induced a transient reduction in creatinine clearance of 35% at Day 3 (p < 0.01). Following IL- 10 administration, an increase in glomerular cellularity was seen, which was maximal at Day 3 (82.7 ± 5.9 nuclei/glomerular cross section versus control 64.6 ± 4.6, 28% ↑; p < 0.001) and maintained at Day 14 (23% ↑ ; p < 0.01). Immuno-histochemical staining for proliferating cell nuclear antigen demonstrated an increased number of proliferating cells per glomerular cross section at day 3 (48% ↑ versus controls; p < 0.05). Staining for α-smooth- muscle actin showed significant labeling only in the glomeruli of IL-10- treated animals; double-labeling with an anti-proliferating cell nuclear antigen Ab demonstrated that some of these mesangial cells were proliferating. Collectively, these results suggest that IL-10 is a growth factor for rat mesangial cells both in vitro and in vivo.
UR - http://www.scopus.com/inward/record.url?scp=0030977038&partnerID=8YFLogxK
M3 - Article
C2 - 9166281
AN - SCOPUS:0030977038
SN - 0023-6837
VL - 76
SP - 619
EP - 628
JO - Laboratory Investigation
JF - Laboratory Investigation
IS - 5
ER -